Get in touch
Genomate Health
The right drug. The first time. Every time.™
Introducing Genomate™
Genomate™ helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their tumor.
Mask for Genomate Health
Better treatment decisions lead to better patient outcomes.
The complexity of cancer, with its numerous types and genetic mutations, has long challenged the medical community. Each cancer is caused by a unique combination of over 6 million potential mutations of 600+ cancer genes.

The targeted therapies that currently exist are focused on only some of the most frequent cancer genes... and often fail to work due to the complex, unique molecular background of each tumor.
The Results and Benefits
of the cancer’s mutations are being considered
when choosing the right treatment (current solutions only target one mutation at a time)
improvement of mPFS (median progression-free survival)
when using Genomate-recommended treatments vs non-Genomate-recommended
of patients can receive
treatments of higher efficacy
when Genomate scores are considered
of pediatric cancer cases have been paired with matching targeted treatment when using Genomate
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patientGenomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
30.2
million
new cancer cases
projected by 2040
16.3
million
cancer deaths
projected by 2040
2nd leading
cause
of deaths (to be
completed with copy)
Better treatment decisions lead to better patient outcomes.
The complexity of cancer, with its numerous types and genetic mutations, has long challenged the medical community. Each cancer is caused by a unique combination of over 6 million potential mutations of 600+ cancer genes.
The targeted therapies that currently exist are focused on only some of the most frequent cancer genes... and often fail to work due to the complex, unique molecular background of each tumor.
Genomate™ is the right solution for:
Genomate Is the
Right Solution For:
Patients
Genomate helps patients receive targeted therapies with the highest chance of success, tailored to their tumor's molecular profile, ultimately improving treatment outcomes and minimizing side effects.
LEARN MORE
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Oncologists
Genomate equips oncologists with actionable insights derived from advanced AI-driven analysis, enabling them to make optimal treatment decisions for each patient thereby saving money on costly and ineffective therapies.
LEARN MORE
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Partners
Genomate partners with healthcare organizations in their fight against cancer by unlocking the true promise of personalized medicine and matching the right treatments to the right patients.Genomate supports partners (payers, cancer centers, labs, pharmaceutical and biotech companies) in selecting cancer treatment options in their fight against cancer.
LEARN MORE
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
05
|
Trusted by
Our growing community of patients, oncologists, and partners are experiencing the transformative power of Genomate in their fight against cancer.
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Join us in revolutionizing personalized
cancer treatment with AI.
Speak with an Expert
Recent News & Events